Recursion Pharmaceuticals
RXRX
#5083
Rank
A$2.62 B
Marketcap
A$4.21
Share price
3.86%
Change (1 day)
-34.14%
Change (1 year)

Recursion Pharmaceuticals (RXRX) - Total debt

Total debt on the balance sheet as of June 2026 : A$99.28 Million

According to Recursion Pharmaceuticals's latest financial reports the company's total debt is A$99.28 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Recursion Pharmaceuticals - Total debt on balance sheet (from 2020 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$0.11 B-33.27%
2024-12-31A$0.17 B134.52%
2023-12-31A$74.37 M-0.77%
2022-12-31A$74.95 M373.42%
2021-12-31A$15.83 M-22.27%
2020-12-31A$20.36 M-11.8%
2019-12-31A$23.09 M